Resitu: minimally invasive surgical technology

Revolutionary devices for safe removal of lesions

Resitu Medical is a Swedish company developing instruments intended for breast lesion biopsy. This revolutionary technology offers the potential to create a paradigm shift in management of breast lesions.

Committed to improving surgical intervention

Resitu Medical was founded in 2019 based on an invention by Dr Per Hedén. In his surgical practice, Dr Hedén, identified a need to remove large tissue samples.

“This minimally invasive platform of devices will in my opinion offer provide completely new solutions to surgeons in offering patients the best possible care. This will be an important new addition to the tools available to surgeons. So many areas can potentially benefit from this new way of addressing removal of large tissue samples lesions” // Dr. Per Hedén

ISO Certified and supporting the Swedish Cancer Society

Resitu Medical is certified according to ISO 13485 for design, development, manufacturing, and sales of electrosurgical instruments for tissue removal.